Abstract
A series of fifteen new 2-[3-(3-chlorophenyl)-5,5-dioxidobenzo[e]pyrazolo[4,3-c][1,2]thiazin-4(2H)-yl]-N′-arylmethyleneacetohydrazides (5a–o) were synthesized and screened for their anti-HIV-1 and cytotoxicity activity. Out of fifteen pyrazolobenzothiazine-based hydrazones, thirteen were found to be active inhibitors of HIV with EC50 values <20 µM. Moreover, the cytotoxicity results showed that most of the compounds were toxic to PBM, CEM and Vero cell lines. This information could be used for structural modifications to acquire good candidates of HIV drugs.
Similar content being viewed by others
References
Abbas EH, Farghaly T (2010) Synthesis, reactions, and biological activity of 1,4-benzothiazine derivatives. Monatsh Chem 141:661–667
Ahmad M, Aslam S, Bukhari MH, Montero C, Detorio M, Parvez M, Schinazi RF (2014) Synthesis of novel pyrazolobenzothiazine 5,5-dioxide derivatives as potent anti-HIV-1 agents. Med Chem Res 23:1309–1319
Altomare A, Cascarano M, Giacovazzo C, Guagliardi A (1993) SIR92. J Appl Cryst 26:343
Aslam S, Ahmad M, Athar M, Ashfaq UA, Gardiner JM, Montero C, Detorio M, Parvez M, Schinazi RF (2014a) Synthesis, molecular docking and antiviral screening of novel N′-substitutedbenzylidene-2-(4-methyl-5,5-dioxido-3-phenylbenzo[e]pyrazolo[4,3-c][1,2]thiazin-1(4H)-yl)acetohydrazides. Med Chem Res 23:2930–2946
Aslam S, Ahmad M, Zia-Ur-Rehman M, Montero C, Detorio M, Parvez M, Schinazi RF (2014b) Synthesis and anti-HIV-1 screening of novel N′-(1-(aryl)ethylidene)-2-(5,5-dioxido-3-phenylbenzo[e]pyrazolo[4,3-c][1,2]thiazin-4(1H)-yl)acetohydrazides. Arch Pharm Res 37:1380–1393
Aslam S, Zaib S, Ahmad M, Gardiner JM, Ahmad M, Hameed A, Furtmann N, Gütschow M, Bajorath J, Iqbal J (2014c) Novel structural hybrids of pyrazolobenzothiazines with benzimidazoles as cholinesterase inhibitors. Eur J Med Chem 78:106–117
Balfour J, Fitton A, Barradell L (1996) Lornoxicam. Drugs 51:639–657
Barazarte A, Camacho J, Domínguez J, Lobo G, Gamboa N, Rodrigues J, Capparelli MV, Álvarez-Larena Á, Andujar S, Enriz D, Charris J (2008) Synthesis, antimalarial activity, structure–activity relationship analysis of thieno-[3,2-b]benzothiazine S, S-dioxide analogs. Bioorg Med Chem 16:3661–3674
Belen’kii MS, Schinazi RF (1994) Multiple drug effect analysis with confidence interval. Antivir Res 25:1–11
Beurskens PT, Admiraal G, Beurskens G, Bosman WP, De Gelder R, Israel R and Smits JMM (1994) The DIRDIF-94 program system, Technical Report of the Crystallography Laboratory, University of Nijmegen, The Netherlands
Clercq ED (2007) The design of drugs for HIV and HCV. Nat Rev Drug Discov 6:1001–1018
Coughlin SA, Danz DW, Robinson RG, Klingbeil KM, Wentland MP, Corbett TH, Waud WR, Zwelling LA, Altschuler E, Bales E, Rake JB (1995) Mechanism of action and antitumor activity of (S)-10-(2,6-dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyridol [1,2,3-de]-[1,4]benzothiazine-6-carboxylic acid (WIN 58161). Biochem Pharmacol 50:111–122
El Safadi Y, Vivet-Boudou V, Marquet R (2007) HIV-1 reverse transcriptase inhibitors. Appl Microbiol Biotechnol 75:723–737
Farrugia LJJ (1997) Appl Cryst 30:565
Gannarapu MR, Vasamsetti SB, Punna N, Royya NK, Pamulaparthy SR, Nanubolu JB, Kotamraju S, Banda N (2014) Synthesis of novel 1,2-benzothiazine 1,1-dioxide-3-ethanone oxime N-aryl acetamide ether derivatives as potent anti-inflammatory agents and inhibitors of monocyte-to-macrophage transformation. Eur J Med Chem 75:143–150
Hadadzadeh H, Salimi M, Weil M, Jannesari Z, Darabi F, Abdi K, Khalaji AD, Sardari S, Ahangari R (2012) The piroxicam complex of copper(II), trans-[Cu(Pir)2(THF)2], and its interaction with DNA. J Mol Struct 1022:172–180
He Y, Kuang Y, Chen F, Wang S, Ji L, De Clercq E, Balzarini J, Pannecouque C (2005) Nonnucleoside HIV-1 reverse transcriptase inhibitors, part 4[1]. Synthesis and anti-HIV activity of N-1-β-carbonyl-6-naphthyl-methyl analogues of HEPT. Monatsh Chem 136:1233–1245
Hooft R (1998) Collect. Nonius B V, Delft
Jochmans D (2008) Novel HIV-1 reverse transcriptase inhibitors. Virus Res 134:171–185
Kamel MM, Ali HI, Anwar MM, Mohamed NA, Soliman AM (2010) Synthesis, antitumor activity and molecular docking study of novel Sulfonamide-Schiff’s bases, thiazolidinones, benzothiazinones and their C-nucleoside derivatives. Eur J Med Chem 45:572–580
Katzmann W (1990) Tenoxicam. Drug Invest 2:31–37
Khalid Z, Siddiqui HL, Ahmad M, Bukhari I (2010a) 2-[2-(3-Chlorophenyl)-2-oxoethyl]-1,2-benzisothiazol-3(2H)-one 1,1-dioxide. Acta Cryst E 66:o617
Khalid Z, Siddiqui HL, Ahmad M, Aslam S, Parvez M (2010b) 3-(3-Chlorobenzoyl)-4-hydroxy-2H-1,2-benzothiazine 1,1-dioxide. Acta Cryst E 66:o995
Kukhanova MK (2012) Anti-HIV nucleoside drugs: a retrospective view into the future. Mol Biol 46:768–779
Mehellou YDCE (2010) Twenty-six years of anti-HIV drug discovery: where do we stand and where do we go? J Med Chem 53:521–538
Meng G, Liu Y, Zheng A, Chen F, Chen W, De Clercq E, Pannecouque C, Balzarini J (2014) Design and synthesis of a new series of modified CH-diarylpyrimidines as drug-resistant HIV non-nucleoside reverse transcriptase inhibitors. Eur J Med Chem 82:600–611
Olkkola K, Brunetto A, Mattila M (1994) Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents. Clin Pharmacokinet 26:107–120
Otwinowski Z, Minor W (1997) Methods Enzymol 276:307–326
Peng H, Liang Y, Chen L, Fu L, Wang H, He H (2011) Efficient synthesis and biological evaluation of 1,3-benzenedicarbonyl dithioureas. Bioorg Med Chem Lett 21:1102–1104
Reed C, Daar E (2006) Novel antiretroviral agents in HIV therapy. Curr Infect Dis Rep 8:489–496
Schinazi RF, Sommadossi JP, Saalmann V, Cannon DL, Xie MY, Hart GC, Smith GA, Hahn EF (1990) Activities of 3′-azido-3′-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1. Antimicrob Agents Chemother 34:1061–1067
Sheldrick GM (2008) Acta Cryst A64:112–122
Stuyver LJ, Lostia S, Adams M, Mathew SJ, Pai SB, Grier J, Tharnish MP, Choi Y, Chong Y, Choo H, Chu KC, Otto JM, Schinazi RF (2002) Antiviral activities and cellular toxicities of modified 2′,3′-dideoxy-2′,3′-didehydrocytidine analogues. Antimicrob Agents Chemother 46:3854–3860
Vadivelan S, Deeksha TN, Arun S, Machiraju PK, Gundla R, Sinha BN, Jagarlapudi SARP (2011) Virtual screening studies on HIV-1 reverse transcriptase inhibitors to design potent leads. Eur J Med Chem 46:851–859
Valuev-Elliston VT, Ivanov AV, Orlinson BS, Gerasimov EN, Brunilina LL, Kochetkov SN, Novakov IA, Navrotskii MB (2012) Synthesis and biological activity of new 6-benzylisocytosine derivatives: non-nucleoside HIV-1 reverse transcriptase inhibitors. Pharm Chem J 46:397–401
Xu Z, Ba M, Zhou H, Cao Y, Tang C, Yang Y, He R, Liang Y, Zhang X, Li Z, Zhu L, Guo Y, Guo C (2014) 2,4,5-Trisubstituted thiazole derivatives: a novel and potent class of non-nucleoside inhibitors of wild type and mutant HIV-1 reverse transcriptase. Eur J Med Chem 85:27–42
Zięba A, Latocha M, Sochanik A (2013) Synthesis and in vitro antiproliferative activity of novel 12(H)-quino[3,4-b][1,4]benzothiazine derivatives. Med Chem Res 22:4158–4163
Acknowledgments
The authors (MA, ZK, SA and MAM) are grateful to Higher Education Commission, Pakistan, and Institute of Chemistry, University of the Punjab, Lahore, for financial assistance. We are also thankful to International Centre for Chemical and Biological Sciences, HEJ Research Institute of Chemistry, University of Karachi, Karachi, for spectral measurements. This work was also supported in part by NIH grant 2P30-AI-050409 and the Department of Veterans Affairs (RFS), USA. The X-ray coordinate of the compounds has been deposited at Cambridge Crystallographic Data Centre with CCDC numbers 881055.
Author information
Authors and Affiliations
Corresponding author
Additional information
We dedicate the research article to Prof. Dr. Hamid Latif Siddiqui (Late) who was our beloved teacher (ZK, SA and MA) and he passed away on July 26, 2011.
Rights and permissions
About this article
Cite this article
Khalid, Z., Aslam, S., Ahmad, M. et al. Anti-HIV activity of new pyrazolobenzothiazine 5,5-dioxide-based acetohydrazides. Med Chem Res 24, 3671–3680 (2015). https://doi.org/10.1007/s00044-015-1411-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-015-1411-z